Swiss National Bank’s Rhythm Pharmaceuticals RYTM Stock Holding History

Swiss National Bank’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$5.73M	Buy	90,600 +1,300	+1%	+$82.1K	﹤0.01%	1212
2025 Q1	$4.73M	Sell	89,300 -900	-1%	-$47.7K	﹤0.01%	1293
2024 Q4	$5.05M	Buy	90,200 +900	+1%	+$50.4K	﹤0.01%	1328
2024 Q3	$4.68M	Buy	89,300 +600	+0.7%	+$31.4K	﹤0.01%	1366
2024 Q2	$3.64M	Sell	88,700 -4,600	-5%	-$189K	﹤0.01%	1465
2024 Q1	$4.04M	Buy	93,300 +3,600	+4%	+$156K	﹤0.01%	1422
2023 Q4	$4.12M	Sell	89,700 -10,200	-10%	-$469K	﹤0.01%	1407
2023 Q3	$2.29M	Buy	99,900 +1,100	+1%	+$25.2K	﹤0.01%	1746
2023 Q2	$1.63M	Buy	98,800 +1,500	+2%	+$24.7K	﹤0.01%	2026
2023 Q1	$1.74M	Sell	97,300 -600	-0.6%	-$10.7K	﹤0.01%	1925
2022 Q4	$2.85M	Buy	97,900 +8,300	+9%	+$242K	﹤0.01%	1656
2022 Q3	$2.2M	Buy	89,600 +6,300	+8%	+$154K	﹤0.01%	1809
2022 Q2	$346K	Hold	83,300	–	–	﹤0.01%	2694
2022 Q1	$960K	Buy	83,300 +5,600	+7%	+$64.5K	﹤0.01%	2429
2021 Q4	$775K	Hold	77,700	–	–	﹤0.01%	2560
2021 Q3	$1.02M	Buy	77,700 +1,700	+2%	+$22.2K	﹤0.01%	2430
2021 Q2	$1.49M	Sell	76,000 -2,700	-3%	-$52.9K	﹤0.01%	2285
2021 Q1	$1.67M	Buy	78,700 +23,700	+43%	+$504K	﹤0.01%	2110
2020 Q4	$1.64M	Hold	55,000	–	–	﹤0.01%	2024
2020 Q3	$1.19M	Buy	55,000 +1,000	+2%	+$21.7K	﹤0.01%	1997
2020 Q2	$1.2M	Sell	54,000 -5,600	-9%	-$125K	﹤0.01%	1999
2020 Q1	$907K	Buy	59,600 +2,500	+4%	+$38K	﹤0.01%	1884
2019 Q4	$1.31M	Buy	57,100 +21,900	+62%	+$503K	﹤0.01%	1983
2019 Q3	$760K	Hold	35,200	–	–	﹤0.01%	2198
2019 Q2	$774K	Buy	35,200 +3,900	+12%	+$85.8K	﹤0.01%	2252
2019 Q1	$858K	Buy	31,300 +1,100	+4%	+$30.2K	﹤0.01%	2148
2018 Q4	$812K	Buy	30,200 +1,600	+6%	+$43K	﹤0.01%	2121
2018 Q3	$834K	Hold	28,600	–	–	﹤0.01%	2243
2018 Q2	$894K	Buy	+28,600	New	+$894K	﹤0.01%	2237